Biocartis Group NV (BCART.BR) Stock Price, Forecast & Analysis

EBR:BCART • BE0974281132

0.29 EUR
+0.01 (+1.75%)
Last: Sep 22, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership

BCART.BR Key Statistics, Chart & Performance

Key Statistics
Market Cap27.24M
Revenue(TTM)57.48M
Net Income(TTM)-65.38M
Shares93.92M
Float83.36M
52 Week High1.46
52 Week Low0.28
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.1
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2015-04-27
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
BCART.BR short term performance overview.The bars show the price performance of BCART.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

BCART.BR long term performance overview.The bars show the price performance of BCART.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of BCART.BR is 0.29 EUR. In the past month the price decreased by -11.31%. In the past year, price decreased by -70.47%.

Biocartis Group NV / BCART Daily stock chart

BCART.BR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
BCART.BR Full Technical Analysis Report

BCART.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BCART.BR. Both the profitability and financial health of BCART.BR have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BCART.BR Full Fundamental Analysis Report

BCART.BR Financial Highlights

Over the last trailing twelve months BCART.BR reported a non-GAAP Earnings per Share(EPS) of -1.1. The EPS decreased by -1.55% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-28.11%
Sales Q2Q%17.8%
EPS 1Y (TTM)-1.55%
Revenue 1Y (TTM)19.08%
BCART.BR financials

BCART.BR Forecast & Estimates

9 analysts have analysed BCART.BR and the average price target is 1.12 EUR. This implies a price increase of 286.9% is expected in the next year compared to the current price of 0.29.

For the next year, analysts expect an EPS growth of 36% and a revenue growth 3.76% for BCART.BR


Analysts
Analysts84.44
Price Target1.12 (286.21%)
EPS Next Y36%
Revenue Next Year3.76%
BCART.BR Analyst EstimatesBCART.BR Analyst Ratings

BCART.BR Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
BCART.BR Ownership

BCART.BR Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
1MDT MEDTRONIC PLC16.05108.279B
2M6 MEDTRONIC PLC15.73106.586B
SHL SIEMENS HEALTHINEERS AG15.8346.756B
1PHIA KONINKLIJKE PHILIPS NV17.3825.46B
PHI1 KONINKLIJKE PHILIPS NV17.3125.287B
PHIA KONINKLIJKE PHILIPS NV17.3525.277B
BIM BIOMERIEUX19.0311.161B
DIA DIASORIN SPA17.173.866B
OBCK OTTOBOCK SE & CO KGAA18.423.663B
AFX CARL ZEISS MEDITEC AG - BR11.42.415B

Related stock screener links

View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges

About BCART.BR

Company Profile

BCART logo image Biocartis Group NV engages in the development of personalized medicine for patients around the world. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 526 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

Company Info

Biocartis Group NV

Generaal de Wittelaan 11B

MALINES (MECHELEN) ANTWERPEN BE

Employees: 526

BCART Company Website

Phone: 3215632600.0

Biocartis Group NV / BCART.BR FAQ

What does Biocartis Group NV do?

Biocartis Group NV engages in the development of personalized medicine for patients around the world. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 526 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.


Can you provide the latest stock price for Biocartis Group NV?

The current stock price of BCART.BR is 0.29 EUR. The price increased by 1.75% in the last trading session.


Does Biocartis Group NV pay dividends?

BCART.BR does not pay a dividend.


What is the ChartMill rating of Biocartis Group NV stock?

BCART.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Is Biocartis Group NV (BCART.BR) expected to grow?

The Revenue of Biocartis Group NV (BCART.BR) is expected to grow by 3.76% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the employee count for BCART stock?

Biocartis Group NV (BCART.BR) currently has 526 employees.


Can you provide the market cap for Biocartis Group NV?

Biocartis Group NV (BCART.BR) has a market capitalization of 27.24M EUR. This makes BCART.BR a Nano Cap stock.